Attached files
| file | filename |
|---|---|
| EX-99.1 - SPECTRASCIENCE INC | v225808_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 13, 2011
SPECTRASCIENCE, INC.
(Exact name of registrant as specified in its charter)
|
Minnesota
(State of other jurisdiction of incorporation)
|
000-13092
(Commission File Number)
|
41-1448837
(I.R.S. Employer Identification No.)
|
11568-11 Sorrento Valley Road, San Diego, CA 92121
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (858) 847-0200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registration under any of the following provisions (see General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
||
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
||
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
||
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
||
The Company’s Letter to Shareholders, which accompanies its Annual Report for the Year Ended December 31, 2010, is attached as Exhibit 99.1.
This Item 7.01 Current Report on Form 8-K contains statements of a forward-looking nature which represent our management's beliefs and assumptions concerning future events. When used in this document and in documents incorporated herein by reference, the words “believe,” “expect,” and similar expressions are intended to identify forward-looking statements, including our expectations regarding joint development agreements, commercialization of and additional commercial applications for our products, and the outlook for our business. Forward-looking statements involve risks, uncertainties and assumptions, and are based on information currently available to us. Actual results may differ materially from those expressed in the forward-looking statements due to many factors, including, without limitation, those disclosed under “Item 1A. Risk Factors” in the Company's Annual Report on Form 10-K for the year ended December 31, 2010 and our quarterly reports on Form 10-Q. We undertake no obligation to update any forward-looking statements to reflect events or circumstances that may arise after the date of this report.
(d) Exhibits
|
Exhibit
Number
|
|
Description
|
|
99.1
|
|
2010 Letter to Shareholders
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Dated: June 14, 2011
|
SPECTRASCIENCE, INC.
By: /s/ Jim Dorst
|
|
|
Jim Dorst
Its: Chief Financial Officer and Chief Operating Officer
|
||
3
|
Exhibit
Number
|
|
Description
|
|
99.1
|
|
2010 Letter to Shareholders
|
4